| 0 (0%) | 08-25 21:54 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 19.69  |
1-year : | 23 |
| Resists | First : | 16.86 |
Second : | 19.69 |
| Pivot price | 14.52 |
|||
| Supports | First : | 14.23 |
Second : | 12.6 |
| MAs | MA(5) : | 14.4 |
MA(20) : | 14.12 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 64.4 |
D(3) : | 42.2 |
| RSI | RSI(14): 68.1 |
|||
| 52-week | High : | 22.91 | Low : | 10.54 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ CRDD ] has closed above the upper band by 10.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 16.89 - 16.95 | 16.95 - 17.02 |
| Low: | 16.25 - 16.32 | 16.32 - 16.4 |
| Close: | 16.5 - 16.63 | 16.63 - 16.75 |
Thu, 13 Aug 2026
Walking with the Herd – Why Africa Must Rethink Its Oldest Economy - African Arguments
Fri, 03 Apr 2026
CRDD ETF Price and Chart — CBOE:CRDD - TradingView
Wed, 01 Apr 2026
Will 30.5″ Wheels Be the Industry’s New 27.5″ Wheel Size? - Bikerumor
Mon, 30 Mar 2026
Cutaneous Rosai–Dorfman disease involving the left ear responsive to systemic glucocorticoid: a case report - Frontiers
Tue, 13 Jan 2026
Facial Cutaneous Rosai-Dorfman Disease Mimicking Sporotrichosis: A Cas | CCID - Dove Medical Press
Tue, 02 Sep 2025
Cutaneous Rosai–Dorfman Disease Mimicking Granulomatous Dermatoses: A Rare Case Report - Wiley Online Library
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|